414 - COMPARATIVE IMPACT OF NIRSEVIMAB ON RSV HOSPITALISATIONS IN NEWBORNS IN SPAIN AND PORTUGAL, 2024-2025 SEASON
A.V. Vilhena, S.C. Campos, A.R. Rodrigues, V.G. Gaio, D.A. Aguilar, M.L. Lozano, S.M. Monge, A.M. Machado, Group SiVIRA
